Clinical outcomes of retrograde intra-arterial chemotherapy concurrent with radiotherapy for elderly oral squamous cell carcinoma patients aged over 80 years old

@inproceedings{Hayashi2017ClinicalOO,
  title={Clinical outcomes of retrograde intra-arterial chemotherapy concurrent with radiotherapy for elderly oral squamous cell carcinoma patients aged over 80 years old},
  author={Yuichiro Hayashi and Kenji Mitsudo and Kaname Sakuma and Masaki Iida and Toshinori Iwai and Hideyuki Nakashima and Yoshiyuki Okamoto and Toshiyuki Koizumi and Senri Oguri and Makoto Hirota and Mitomu Kioi and Izumi Koike and M. Hata and Iwai Tohnai},
  booktitle={Radiation oncology},
  year={2017}
}
BACKGROUND The aim of this retrospective observational study was to evaluate toxicities, overall survival, and locoregional control in elderly oral squamous cell carcinoma patients who had undergone retrograde intra-arterial chemotherapy combined with radiotherapy. METHODS Thirty-one elderly patients over 80 years old with oral squamous cell carcinoma were enrolled in present study. The treatment schedule consisted of intra- arterial chemotherapy (docetaxel, total 60 mg/m2; cisplatin, total… CONTINUE READING